Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti–Tim-3 antibody in vivo
Open Access
- 21 May 2007
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 204 (6), 1289-1294
- https://doi.org/10.1084/jem.20062093
Abstract
T cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) is a surface molecule that is preferentially expressed on activated Th1 cells in comparison to Th2 cells. Blockade of Tim-3 has been shown to enhance Th1-driven pathology in vivo, suggesting that blockade of Tim-3 may improve the development of Th2-associated responses such as allergy. To examine the effects of Tim-3 blockade on the Th2 response in vivo, we administered anti-Tim-3 antibody during pulmonary inflammation induced by transfer of ovalbumin (OVA)-reactive Th2 cells, and subsequent aerosol challenge with OVA. In this model, anti-Tim-3 antibody treatment before each airway challenge significantly reduced airway hyperreactivity, with a concomitant decrease in eosinophils and Th2 cells in the lung. We examined Th1 and Th2 cytokine levels in the lung after allergen challenge and found that pulmonary expression of the Th2 cytokine IL-5 was significantly reduced, whereas IFN-gamma levels were significantly increased by anti-Tim-3 antibody treatment. Thus, blocking Tim-3 function has a beneficial effect during pulmonary inflammation by skewing the Th2 response toward that of a Th1 type, suggesting an important role for Tim-3 in the regulation of allergic disease.Keywords
This publication has 25 references indexed in Scilit:
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral toleranceNature Immunology, 2003
- Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological toleranceNature Immunology, 2003
- Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune diseaseNature, 2002
- Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene familyNature Immunology, 2001
- IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthmaJournal of Allergy and Clinical Immunology, 2000
- T Helper 1 Cells and Interferon γ Regulate Allergic Airway Inflammation and Mucus ProductionThe Journal of Experimental Medicine, 1999
- Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil countsEuropean Respiratory Journal, 1996
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989